EP2726511
Samsetningar, notkun og aðferðir til meðferðar við efnaskiptaröskunum og sjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.6.2012EP published:
7.8.2019EP application number:
12807786.4
EP translation filed:
27.9.2019Grant published:
15.10.2019EPO information:
European Patent Register
Max expiry date:
28.6.2032Expiry date:
28.6.2026Next due date:
30.6.2026
Title:
COMPOSITIONS, USES AND METHODS FOR TREATMENT OF METABOLIC DISORDERS AND DISEASES
Timeline
Today
29.6.2012EP application
7.8.2019EP Publication
27.9.2019Translation submitted
15.10.2019Registration published
28.6.2026Expires
Owner
Name:
NGM Biopharmaceuticals, Inc.Address:
333 Oyster Point Blvd., 94080, South San Francisco, CA, US
Inventor
Name:
LING, LeiAddress:
Foster City, CA, US
Name:
LINDHOUT, Darrin, A.Address:
Mountain View, CA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161504128 PDate:
1.7.2011Country:
US
Number:
201161515126 PDate:
4.8.2011Country:
US
Classification
Categories:
C07K 19/00, C07K 14/50, C12N 15/62, A61K 38/18, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 2.6.2020
Expires: 28.6.2021
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 2.6.2021
Expires: 28.6.2022
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 1.6.2022
Expires: 28.6.2023
Payer: Patice ehf.
Number: 12
Paid: 11.6.2023
Expires: 28.6.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 31.5.2024
Expires: 28.6.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 18.6.2025
Expires: 28.6.2026
Payer: Árnason Faktor ehf.